The healthcare landscape is evolving. Pharma must evolve with it. We must rethink the value we bring, and therefore the development processes we use. We must introduce new technology, work better with regulators and truly understand which patient outcomes to aim for.
At the 13th annual Pharma Japan Conference, pharma decision-makers will draw new blueprints for sustained clinical success, combining new insights, ‘patient-preferred’ trials, smart data gathering and a digital transformation. Join this event to breathe new life into your approach.
From Japan to the world: How you can gain a higher quality of data, earlier, and provide insights to other countries
Smarter clinical trials: Use new technology to drive efficiency and find new endpoints
Boost patient engagement in the design and implementation of your trials for improved recruitment and retention
Collaborative research as the key to pharma’s sustainability: Why the ‘One Japan’ model in clinical trials makes sense
Alexandre de Muralt, Representative Director and President, Merck Biopharma Co., Ltd.Reuters Events Pharma Japan is a valuable platform for our industry to network, exchange views and anticipate our industry trends and evolution.
4 business-critical conference streams
Reuters Events Pharma Japan VIRTUAL 2020 will cover all key topics with four themes: Keynote, Digital Clinical Innovation, RWE & Medical and Commercial Excellence.
Connect with fellow senior-level attendees in a personalized and user-friendly way. Even you are at your home, we can come together and work towards a better pharma through live Q&A, online networking and workshop sessions.
The most senior-level pharma event in Japan
You won’t find a better place to meet your peers since over 80% of the pharma attendees are director-level or above.
Other events say they attract senior executives - people with clout, budget, ideas and a mission. We really mean it.
77% of attendees are director-level and above
Reuters Events Pharma Japan attracts a variety of job titles, geographies, cultures and opinions create a rich tapestry.
Join one of the 30+ discussions taking place on topics including digital marketing, commercial excellence, patient-centricity, market access, RWE and medical affairs.
Hear from healthcare innovators on the new technologies, ideas and science that is set to disrupt the very nature of healthcare and biopharma.
Grab a coffee and a pastry and recharge your batteries, and your phones!
Find out how digital clinical trials are disrupting clinical development and creating truly patient-centric trials.
Satoru Noguchi, Ex-executive Pharma and Principal, GlobalMindsetAs times change, Reuters Events Pharma Japan always captures the current and future trends to help us grow our business.
Haider Alleg, Global Head of Digital Excellence / GMO, Ferring International CenterReuters Events Pharma Japan is a thriving community of experts exchanging opinions and finding answers. You will meet peers who understand and will help to propel your ideas forward.
Yasuyuki Katayama, Corporate Officer, Country Medical Director and Head of Medical Japan, Pfizer Japan Inc.Reuters Events Pharma Japan is where leaders gather and find direction, opportunities and partnerships.
Katsunori Ohyama, Director, Severe asthma dedicated sales force, GlaxoSmithKline K.K.Reuters Events Pharma Japan is always at the forefront of the pharma industry’s next movement.
Craig Lipset, former Head of Innovation at PfizerNow more than ever, society is looking to medicine developers for answers. Quickly moving important gatherings online is vital for innovation continuity and keeping us all making progress for delivering new medicines.
Get in touch with the Reuters Events: Pharma Management Team Japan
Kana Chia Head of Japan
Hiromasa Araki Business Development Executive, Japan
Blair Gottscho VP Operations
Izzy Gladstone Head of Marketing
Henry Payne Director of Business Development